WHO ICTRP trial

Evaluation of the effect of high flow oxygen delivery under different…

IRCT20200611047727N4 · Iranian Registry of Clinical Trials (IRCT) · Recruiting

Key facts

Trial ID IRCT20200611047727N4
Public title Evaluation of the effect of high flow oxygen delivery under different temperatures in COVID-19 patients
Scientific title The effectiveness of oxygen delivery through high flow nasal cannula (HFNC) with different temperatures in improving the clinical symptoms of COVID-19 patients
Primary sponsor Shahid Beheshti University of Medical Sciences
Registry Iranian Registry of Clinical Trials (IRCT)
Recruitment status Recruiting
Study type interventional
Phase 2
Countries Iran (Islamic Republic of)
Conditions COVID-19. COVID-19;U07.01
Interventions Intervention 1: First intervention group: In this group, patients undergo oxygen therapy with a high-flow device for "24 hours". This device transmits hot and humid air with high flow (up to 60 l / min) through the nasal cannula to…
Registration date Apr 28, 2021
Target size 30
Registry page irct.behdasht.gov.ir

At a glance

  • No Results available

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About WHO ICTRP trial registrations

The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.

Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date:

Browse all WHO ICTRP trial registrations